Dataset Information

CORNELIUS (COloRectal CaNcEr in ELderly MultImorbide PopUlationS): a non-interventional observational study

ABSTRACT: Interventions: Group 1: Efficacy and safety profile of oxaliplatin or axinotecan will be documented under routine practice conditions in patients where treatment with oxaliplatin or axinotecan is indicated. No further pre-selection is allowed. Descriptive analysis will be performed. Side effects which were not observed so far will be reported Primary outcome(s): Efficacy and tolerability of oxaliplatin or axinotecan in routine practice Study Design: Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: treatment

DISEASE(S): Malignant Neoplasm Of Colon

PROVIDER: 2432693 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Similar Datasets

Project description:Time-course and concentration-effect experiments with multiple time points and drug concentrations provide far more valuable information than experiments with just two design-points (treated vs. control), as commonly performed in most microarray studies. Analysis of the data from such complex experiments, however, remains a challenge. Here we present a semi-automated method for fitting time profiles and concentration-effect patterns, simultaneously, to gene expression data. The submodels for time-course included exponential increase and decrease models with parameters such as initial expression level, maximum effect, and rate-constant (or half-time). The submodel for concentration-effect was a 4-parameter Hill model. The method was applied to an Affymetrix HG-U95Av2 dataset consisting of 51 arrays. The specific study focused on the effects of two platinum drugs, cisplatin and oxaliplatin, on A2780 human ovarian carcinoma cells. Replicates were available at most time points and concentrations. Eighteen genes were selected; time-course and concentration-effect were modeled simultaneously. Comparisons of model parameters helped distinguish genes with different expression patterns between the two drug treatments. This overall paradigm can help in understanding the molecular mechanisms of the agents, and the timing of their actions. Experiment Overall Design: For the time-course experiments, samples were exposed to IC90 concentrations of oxaliplatin (32 Î¼M) or cisplatin (25 Î¼M) for 2 hours, and then allowed to grow in drug free medium. Cells were harvested and processed at the following times: before treatment, immediately after treatment (0 h), and at 2 h, 6 h, 16 h and 24 h after treatment. Control experiments were done following a similar design, but with exposure to drug-free medium. For the concentration-effect experiments, samples were treated with specific growth-inhibitory concentrations of cisplatin or oxaliplatin for 2 hours. The previously-estimated IC10, IC25, IC50, IC75 and IC90 concentrations (for 2 hr drug exposure; 72 hr total growth) for cisplatin and oxaliplatin growth inhibition of A2780 were 2.6, 4.0, 6.4, 12 and 25 Î¼M and 2.8, 4.8, 8.5, 17 and 32 Î¼M respectively. Cells were harvested and processed at 16 h after completion of treatment

Dataset Information

CORNELIUS (COloRectal CaNcEr in ELderly MultImorbide PopUlationS): a non-interventional observational study

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets